封面
市場調查報告書
商品編碼
2040370

美國周邊血管醫療設備及配件市場規模、佔有率及趨勢分析報告:依產品、應用、最終用途及細分市場分類(2026-2033 年)

U.S. Peripheral Vascular Devices And Accessories Market Size, Share & Trends Analysis Report By Product, By Application, By End Use, And Segment Forecasts, 2026 - 2033

出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

美國周邊血管醫療設備及配件市場概述

據估計,2025年美國周邊血管醫療設備及配件市場價值為41億美元,預計2033年將達到62億美元。

預計從 2026 年到 2033 年,該行業將以 5.1% 的複合年成長率成長。這一成長是由人口老化和生活方式因素導致周邊動脈疾病(PAD) 盛行率不斷上升所驅動的。

微創手術和創新醫療設備等技術進步正在提高治療效果。此外,老年人口不斷成長,他們更容易患血管疾病,這也推動了對血管介入治療和醫療設備的需求增加。

在臨床需求不斷成長、技術進步和醫療模式不斷演變的推動下,市場正經歷著重大變革。微創手術的興起也促進了市場成長。

目錄

第1章:調查方法和範圍

第2章執行摘要

第3章:美國周邊血管醫療設備及配件市場:影響因素、趨勢及範圍

  • 市場譜系展望
  • 市場動態
  • 美國周邊血管靜脈通路裝置及配件市場分析工具
  • 法律規範

第4章:美國周邊血管醫療設備及配件市場:產品細分分析(收入;銷售量,千台;2021-2033 年)

  • 2025 年及 2033 年產品特定市佔率分析
  • 美國周邊血管醫療設備及配件市場:依產品分類,2021-2033年
  • 外周支架
    • 髂動脈支架
    • 股動脈支架
    • 頸動脈支架
    • 腎動脈支架
    • 其他
  • PTA球囊
  • 導管
    • 血管造影術導管
    • 引導管
    • IVUS/OCT導管
  • 用於修復血管內動脈瘤的血管支架
    • 胸主動脈瘤血管支架
    • 腹部血管內動脈瘤血管支架
  • 斑塊修飾裝置
    • 動脈粥狀硬化斑塊切除術裝置
    • 血栓除去裝置
  • 末梢用配件
    • 導管導引線
    • 周邊血管閉塞裝置
    • 球囊擴張設備
    • 導引鞘
  • 下腔靜脈濾器
    • 永久過濾器
    • 可回收過濾器
  • 血流動力學流速控制裝置
    • 慢性完全閉塞裝置
    • 栓塞預防裝置

第5章:美國周邊血管醫療設備及配件市場:基於應用的估算與趨勢分析

  • 按應用領域分類的市場佔有率分析(2025 年和 2033 年)
  • 美國周邊血管醫療設備及配件市場:依應用領域分類,2021-2033年
  • 周邊動脈疾病(PAD)
  • 動脈瘤
  • 靜脈疾病
  • 其他

第6章:美國周邊血管醫療設備及配件市場:依最終用途分類的估算與趨勢分析

  • 按應用領域分類的市場佔有率分析(2025 年和 2033 年)
  • 美國周邊血管醫療設備及配件市場:依最終用途分類,2021-2033年
  • 醫院
  • 門診手術中心
  • 其他

第7章 競爭情勢

  • 公司和競爭對手分類(主要創新者、市場領導、新興企業)
  • 企業市場占有率分析,2025 年
  • Competitive Landscape & Strategic Opportunity Analysis for NIPRO & Terumo Corporation in the US Vascular Devices Market
    • 競爭定位矩陣
    • 銷售網路實力比較
    • 技術領導力分析
    • 投資和戰略洞察
    • 對Nipro和Terumo Corporation面臨的競爭威脅評估
    • 找出競爭不足的領域。
    • 雅培
    • Terumo Corporation醫療株式會社
    • 尼普羅
    • Medtronic
    • 波士頓科學公司
    • 科迪斯
    • Royal Phillips NV,
    • 血管動力學。
    • 朝日英特克株式會社
    • BD
    • 泰利福公司(Biotronic)
    • 愛德華生命科學公司
    • B. Braun SE
    • WL Gore & Associates
    • Merit Medical Systems, Inc.
    • 廚師
Product Code: GVR-4-68039-243-5

U.S. Peripheral Vascular Devices And Accessories Market Summary

The U.S. peripheral vascular devices and accessories market size was estimated at USD 4.1 billion in 2025 and is projected to reach USD 6.2 billion by 2033, growing at a CAGR of 5.1% from 2026 to 2033. The industry is driven by the rising prevalence of peripheral arterial disease (PAD), fueled by aging and lifestyle factors.

Technological advancements, such as minimally invasive procedures and innovative devices, are enhancing treatment effectiveness. In addition, the growing geriatric population, more prone to vascular conditions, is increasing the demand for vascular interventions and devices.

The market is undergoing a significant transformation driven by rising clinical demand, technological advancements, and evolving care models. The shift toward minimally invasive procedures are also driving the market growth.

U.S. Peripheral Vascular Devices And Accessories Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. peripheral vascular devices and accessories market report based on product, application, and end use:

  • Product Outlook (Revenue, USD Million, Unit Volume, In Thousand Units, 2021 - 2033)
  • Peripheral Stents
    • Iliac Artery Stents
    • Femoral Artery Stents
    • Carotid Artery Stents
    • Renal Artery Stents
    • Others
  • PTA Balloons
  • Catheters
    • Angiography Catheters
    • Guiding Catheters
    • IVUS/OCT Catheters
  • Endovascular Aneurysm Repair Stent Grafts
    • Thoracic Endovascular Aneurysm Stent Grafts
    • Abdominal Endovascular Aneurysm Stent Grafts
  • Plaque Modification Devices
    • Atherectomy Devices
    • Thrombectomy Devices
  • Peripheral Accessories
    • Guidewires
    • Workhorse Guidewires
    • Specialty Guidewires
    • Extra Support Guidewires
    • Frontline Finesse Guidewires
    • Peripheral Vascular Closure Devices
    • Balloon Inflation Devices
    • Introducer Sheaths
  • Inferior Vena Cava Filters
    • Permanent Filters
    • Retrievable Filters
  • Hemodynamic Flow Alteration Devices
    • Chronic Total Occlusion Devices
    • Embolic Protection Devices
  • Application Outlook (Revenue, USD Million, Unit Volume, In Thousand Units, 2021 - 2033)
  • Peripheral Arterial Disease (PAD)
  • Aneurysms
  • Venous Diseases
  • Others
  • End Use Outlook (Revenue, USD Million, Unit Volume, In Thousand Units, 2021 - 2033)
  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End-use
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
    • 1.7.3. Three pillars of market estimation
    • 1.7.4. Market modeling & forecasting
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End Use outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Peripheral Vascular Devices and Accessories Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence & increasing diagnosis of peripheral artery disease (PAD)
      • 3.2.1.2. Growing burden of diabetes and diabetes related PAD
      • 3.2.1.3. Increasing adoption of minimally invasive endovascular procedures
      • 3.2.1.4. Technologically advanced product launches in peripheral vascular devices
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High treatment costs
      • 3.2.2.2. Regulatory and approval challenges
    • 3.2.3. Market restraint analysis
      • 3.2.3.1. High treatment costs
      • 3.2.3.2. Product recalls and safety concerns
    • 3.2.4. Market opportunity analysis
      • 3.2.4.1. Growing office based laboratories for peripheral vascular interventions
      • 3.2.4.2. AI based predictive modeling to optimize endovascular intervention outcomes in PAD
      • 3.2.4.3. Rising revolution in peripheral CTO intervention devices
    • 3.2.5. Market challenge analysis
      • 3.2.5.1. Declining medicare reimbursements
      • 3.2.5.2. Shortage of skilled specialists for complex peripheral vascular interventions
  • 3.3. U.S. Peripheral Vascular Access Devices and Accessories Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
  • 3.4. Regulatory Framework

Chapter 4. U.S. Peripheral Vascular Devices and Accessories Market Segment Analysis, By Product (Revenue in USD Million; Unit Volume, In Thousand Units; 2021 - 2033)

  • 4.1. Definition and Scope
  • 4.2. Product Market Share Analysis, 2025 & 2033
  • 4.3. Segment Dashboard
  • 4.4. U.S. Peripheral Vascular Devices and Accessories Market, by Product, 2021 to 2033 (USD Million)
  • 4.5. Peripheral Stents
    • 4.5.1. Peripheral stents market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.5.2. Peripheral stents market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
    • 4.5.3. Iliac artery stents
      • 4.5.3.1. Iliac artery stents market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.5.3.2. Iliac artery stents market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
    • 4.5.4. Femoral artery stents
      • 4.5.4.1. Femoral artery stents market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.5.4.2. Femoral artery stents market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
    • 4.5.5. Carotid artery stents
      • 4.5.5.1. Carotid artery stents market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.5.5.2. Carotid artery stents market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
    • 4.5.6. Renal artery stents
      • 4.5.6.1. Renal artery stents market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.5.6.2. Renal artery stents market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
    • 4.5.7. Others
      • 4.5.7.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.5.7.2. Others market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
  • 4.6. PTA Balloons
    • 4.6.1. PTA balloons market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.6.2. PTA balloons market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
  • 4.7. Catheters
    • 4.7.1. Catheters market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.7.2. Catheters market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
    • 4.7.3. Angiography catheters
      • 4.7.3.1. Angiography catheters market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.7.3.2. Angiography catheters market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
    • 4.7.4. Guiding catheters
      • 4.7.4.1. Guiding catheters market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.7.4.2. Guiding catheters market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
    • 4.7.5. IVUS/OCT Catheters
      • 4.7.5.1. IVUS/OCT catheters market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.7.5.2. IVUS/OCT catheters market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
  • 4.8. Endovascular Aneurysm Repair Stent Grafts
    • 4.8.1. Endovascular aneurysm repair stent grafts market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.8.2. Endovascular aneurysm repair stent grafts market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
    • 4.8.3. Thoracic endovascular aneurysm stent grafts
      • 4.8.3.1. Thoracic endovascular aneurysm stent grafts market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.8.3.2. Thoracic endovascular aneurysm stent grafts market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
    • 4.8.4. Abdominal endovascular aneurysm stent grafts
      • 4.8.4.1. Abdominal endovascular aneurysm stent grafts market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.8.4.2. Abdominal endovascular aneurysm stent grafts market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
  • 4.9. Plaque Modification Devices
    • 4.9.1. Plaque modification devices market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.9.2. Plaque modification devices market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
    • 4.9.3. Atherectomy devices
      • 4.9.3.1. Atherectomy devices market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.9.3.2. Atherectomy devices market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
    • 4.9.4. Thrombectomy devices
      • 4.9.4.1. Thrombectomy devices market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.9.4.2. Thrombectomy devices market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
  • 4.10. Peripheral Accessories
    • 4.10.1. Peripheral accessories market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.10.2. Peripheral accessories market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
    • 4.10.3. Guidewires
      • 4.10.3.1. Guidewires market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.10.3.2. Guidewires market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
      • 4.10.3.3. Workhorse guidewires
        • 4.10.3.3.1. Workhorse guidewires market estimates and forecasts, 2021 to 2033 (USD Million)
        • 4.10.3.3.2. Workhorse guidewires market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
      • 4.10.3.4. Specialty guidewires
        • 4.10.3.4.1. Specialty guidewires market estimates and forecasts, 2021 to 2033 (USD Million)
        • 4.10.3.4.2. Specialty guidewires market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
      • 4.10.3.5. Extra support guidewires
        • 4.10.3.5.1. Extra support guidewires market estimates and forecasts, 2021 to 2033 (USD Million)
        • 4.10.3.5.2. Extra support guidewires market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
      • 4.10.3.6. Frontline finesse guidewires
        • 4.10.3.6.1. Frontline finesse guidewires market estimates and forecasts, 2021 to 2033 (USD Million)
        • 4.10.3.6.2. Frontline finesse guidewires market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
    • 4.10.4. Peripheral vascular closure devices
      • 4.10.4.1. Peripheral vascular closure devices market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.10.4.2. Peripheral vascular closure devices market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
    • 4.10.5. Balloon inflation devices
      • 4.10.5.1. Balloon inflation devices market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.10.5.2. Balloon inflation devices market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
    • 4.10.6. Introducer sheaths
      • 4.10.6.1. Introducer sheaths market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.10.6.2. Introducer sheaths market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
  • 4.11. Inferior vena cava filters
    • 4.11.1. Inferior vena cava filters market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.11.2. Inferior vena cava filters market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
    • 4.11.3. Permanent filters
      • 4.11.3.1. Permanent filters market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.11.3.2. Permanent filters market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
    • 4.11.4. Retrievable filters
      • 4.11.4.1. Retrievable filters market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.11.4.2. Retrievable filters market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
  • 4.12. Hemodynamic flow alteration devices
    • 4.12.1. Hemodynamic flow alteration devices market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.12.2. Hemodynamic flow alteration devices market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
    • 4.12.3. Chronic total occlusion devices
      • 4.12.3.1. Chronic total occlusion devices market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.12.3.2. Chronic total occlusion devices market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
    • 4.12.4. Embolic protection devices
      • 4.12.4.1. Embolic protection devices market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.12.4.2. Embolic protection devices market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)

Chapter 5. U.S. Peripheral Vascular Devices and Accessories Market: Application Estimates & Trend Analysis

  • 5.1. Definition and Scope
  • 5.2. Application Market Share Analysis, 2025 & 2033
  • 5.3. Segment Dashboard
  • 5.4. U.S. Peripheral Vascular Devices and Accessories Market, by Application, 2021 to 2033 (USD Million)
  • 5.5. Peripheral Arterial Disease (PAD)
    • 5.5.1. Peripheral Arterial Disease (PAD) market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.6. Aneurysms
    • 5.6.1. Aneurysms market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.7. Venous Diseases
    • 5.7.1. Venous diseases market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.8. Others
    • 5.8.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. U.S. Peripheral Vascular Devices and Accessories Market: End Use Estimates & Trend Analysis

  • 6.1. Definition and Scope
  • 6.2. Application Market Share Analysis, 2025 & 2033
  • 6.3. Segment Dashboard
  • 6.4. U.S. Peripheral Vascular Devices and Accessories Market, by End Use, 2021 to 2033 (USD Million)
  • 6.5. Hospitals
    • 6.5.1. Hospitals market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6. Ambulatory Surgical Centers
    • 6.6.1. Ambulatory surgical centers market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.7. Others
    • 6.7.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization (Key innovators, market leaders, emerging players)
  • 7.2. Company Market Share Analysis, 2025
  • 7.3. Competitive Landscape & Strategic Opportunity Analysis for NIPRO & Terumo Corporation in the U.S. Vascular Devices Market
    • 7.3.1. Competitive positioning matrix
    • 7.3.2. Distribution strength comparison
    • 7.3.3. Technology leadership analysis
    • 7.3.4. Investment & strategic insights
    • 7.3.5. Competitive threat assessment for NIPRO & Terumo Corporation
    • 7.3.6. Competitive white space identification
    • 7.3.7. Abbott
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Terumo Medical Corporation
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Nipro
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Medtronic
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Boston Scientific Corporation
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Cordis
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Koninklijke Philips N.V.,
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives
    • 7.3.14. AngioDynamics.
      • 7.3.14.1. Company overview
      • 7.3.14.2. Financial performance
      • 7.3.14.3. Product benchmarking
      • 7.3.14.4. Strategic initiatives
    • 7.3.15. ASAHI INTECC CO., LTD.
      • 7.3.15.1. Company overview
      • 7.3.15.2. Financial performance
      • 7.3.15.3. Product benchmarking
      • 7.3.15.4. Strategic initiatives
    • 7.3.16. BD
      • 7.3.16.1. Company overview
      • 7.3.16.2. Financial performance
      • 7.3.16.3. Product benchmarking
      • 7.3.16.4. Strategic initiatives
    • 7.3.17. Teleflex Incorporated. (Biotronik)
      • 7.3.17.1. Company overview
      • 7.3.17.2. Financial performance
      • 7.3.17.3. Product benchmarking
      • 7.3.17.4. Strategic initiatives
    • 7.3.18. Edward Lifesciences Corporation
      • 7.3.18.1. Company overview
      • 7.3.18.2. Financial performance
      • 7.3.18.3. Product benchmarking
      • 7.3.18.4. Strategic initiatives
    • 7.3.19. B. Braun SE
      • 7.3.19.1. Company overview
      • 7.3.19.2. Financial performance
      • 7.3.19.3. Product benchmarking
      • 7.3.19.4. Strategic initiatives
    • 7.3.20. W. L. Gore & Associates, Inc.
      • 7.3.20.1. Company overview
      • 7.3.20.2. Financial performance
      • 7.3.20.3. Product benchmarking
      • 7.3.20.4. Strategic initiatives
    • 7.3.21. Merit Medical Systems, Inc.
      • 7.3.21.1. Company overview
      • 7.3.21.2. Financial performance
      • 7.3.21.3. Product benchmarking
      • 7.3.21.4. Strategic initiatives
    • 7.3.22. Cook
      • 7.3.22.1. Company overview
      • 7.3.22.2. Financial performance
      • 7.3.22.3. Product benchmarking
      • 7.3.22.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 U.S. Peripheral Vascular Devices and Accessories Market, By Product, 2021 - 2033 (USD Million)
  • Table 3 U.S. Peripheral Vascular Devices and Accessories Market, By Application, 2021 - 2033 (USD Million)
  • Table 4 U.S. Peripheral Vascular Devices and Accessories Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 US Peripheral Vascular Devices and Accessories Market Segmentation
  • Fig. 8 Market Snapshot, 2024
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Swot Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 US Peripheral Vascular Devices and Accessories Market: Product Outlook Key Takeaways
  • Fig. 15 US Peripheral Vascular Devices and Accessories Market: Product Movement Analysis
  • Fig. 16 Peripheral Stents Market, 2021 - 2033 (USD Million)
  • Fig. 17 Peripheral Stents Market, 2021 - 2033 (Unit Volume, In Thousand Units)
  • Fig. 18 Iliac Artery Stents Market, 2021 - 2033 (USD Million)
  • Fig. 19 Iliac Artery Stents Market, 2021 - 2033 (Unit Volume, In Thousand Units)
  • Fig. 20 Femoral Artery Stents Market, 2021 - 2033 (USD Million)
  • Fig. 21 Femoral Artery Stents Market, 2021 - 2033 (Unit Volume, In Thousand Units)
  • Fig. 22 Carotid Artery Stents Market, 2021 - 2033 (USD Million)
  • Fig. 23 Carotid Artery Stents Market, 2021 - 2033 (Unit Volume, In Thousand Units)
  • Fig. 24 Renal Artery Stents Market, 2021 - 2033 (USD Million)
  • Fig. 25 Carotid Artery Stents Market, 2021 - 2033 (Unit Volume, In Thousand Units)
  • Fig. 26 Others Market, 2021 - 2033 (USD Million)
  • Fig. 27 Others Market, 2021 - 2033 (Unit Volume, In Thousand Units)
  • Fig. 28 PTA Balloons Market, 2021 - 2033 (USD Million)
  • Fig. 29 PTA Balloons Market, 2021 - 2033 (Unit Volume, In Thousand Units)
  • Fig. 30 Catheters Market, 2021 - 2033 (USD Million)
  • Fig. 31 Catheters Market, 2021 - 2033 (Unit Volume, In Thousand Units)
  • Fig. 32 Angiography Catheters Market, 2021 - 2033 (USD Million)
  • Fig. 33 Angiography Catheters Market, 2021 - 2033 (Unit Volume, In Thousand Units)
  • Fig. 34 Guiding Catheters Market, 2021 - 2033 (USD Million)
  • Fig. 35 Guiding Catheters Market, 2021 - 2033 (Unit Volume, In Thousand Units)
  • Fig. 36 IVUS/OCT Catheters Market, 2021 - 2033 (USD Million)
  • Fig. 37 IVUS/OCT Catheters Market, 2021 - 2033 (Unit Volume, In Thousand Units)
  • Fig. 38 Endovascular Aneurysm Repair Stent Grafts Market, 2021 - 2033 (USD Million)
  • Fig. 39 Endovascular Aneurysm Repair Stent Grafts Market, 2021 - 2033 (Unit Volume, In Thousand Units)
  • Fig. 40 Thoracic Endovascular Aneurysm Stent Grafts Market, 2021 - 2033 (USD Million)
  • Fig. 41 Thoracic Endovascular Aneurysm Stent Grafts Market, 2021 - 2033 (Unit Volume, In Thousand Units)
  • Fig. 42 Abdominal Endovascular Aneurysm Stent Grafts Market, 2021 - 2033 (USD Million)
  • Fig. 43 Abdominal Endovascular Aneurysm Stent Grafts Market, 2021 - 2033 (Unit Volume, In Thousand Units)
  • Fig. 44 Plaque Modification Devices Market, 2021 - 2033 (USD Million)
  • Fig. 45 Plaque Modification Devices Market, 2021 - 2033 (Unit Volume, In Thousand Units)
  • Fig. 46 Atherectomy Devices Market, 2021 - 2033 (USD Million)
  • Fig. 47 Atherectomy Devices Market, 2021 - 2033 (Unit Volume, In Thousand Units)
  • Fig. 48 Thrombectomy Devices Market, 2021 - 2033 (USD Million)
  • Fig. 49 Thrombectomy Devices Market, 2021 - 2033 (Unit Volume, In Thousand Units)
  • Fig. 50 Peripheral Accessories Market, 2021 - 2033 (USD Million)
  • Fig. 51 Peripheral Accessories Market, 2021 - 2033 (Unit Volume, In Thousand Units)
  • Fig. 52 Guidewires Market, 2021 - 2033 (USD Million)
  • Fig. 53 Guidewires Market, 2021 - 2033 (Unit Volume, In Thousand Units)
  • Fig. 54 Workhorse Guidewires Market, 2021 - 2033 (USD Million)
  • Fig. 55 Workhorse Guidewires Market, 2021 - 2033 (Unit Volume, In Thousand Units)
  • Fig. 56 Specialty Guidewires Market, 2021 - 2033 (USD Million)
  • Fig. 57 Specialty Guidewires Market, 2021 - 2033 (Unit Volume, In Thousand Units)
  • Fig. 58 Extra Support Guidewires Market, 2021 - 2033 (USD Million)
  • Fig. 59 Extra Support Guidewires Market, 2021 - 2033 (Unit Volume, In Thousand Units)
  • Fig. 60 Frontline Finesse Guidewires Market, 2021 - 2033 (USD Million)
  • Fig. 61 Frontline Finesse Guidewires Market, 2021 - 2033 (Unit Volume, In Thousand Units)
  • Fig. 62 Peripheral Vascular Closure Devices Market, 2021 - 2033 (USD Million)
  • Fig. 63 Peripheral Vascular Closure Devices Market, 2021 - 2033 (Unit Volume, In Thousand Units)
  • Fig. 64 Balloon Inflation Devices Market, 2021 - 2033 (USD Million)
  • Fig. 65 Balloon Inflation Devices Market, 2021 - 2033 (Unit Volume, In Thousand Units)
  • Fig. 66 Introducer Sheaths Market, 2021 - 2033 (USD Million)
  • Fig. 67 Introducer Sheaths Market, 2021 - 2033 (Unit Volume, In Thousand Units)
  • Fig. 68 Inferior Vena Cava Filters Market, 2021 - 2033 (USD Million)
  • Fig. 69 Inferior Vena Cava Filters Market, 2021 - 2033 (Unit Volume, In Thousand Units)
  • Fig. 70 Permanent Filters Market, 2021 - 2033 (USD Million)
  • Fig. 71 Permanent Filters Market, 2021 - 2033 (Unit Volume, In Thousand Units)
  • Fig. 72 Retrievable Filters Market, 2021 - 2033 (USD Million)
  • Fig. 73 Retrievable Filters Market, 2021 - 2033 (Unit Volume, In Thousand Units)
  • Fig. 74 Hemodynamic Flow Alteration Devices Market, 2021 - 2033 (USD Million)
  • Fig. 75 Hemodynamic Flow Alteration Devices Market, 2021 - 2033 (Unit Volume, In Thousand Units)
  • Fig. 76 Chronic Total Occlusion Devices Market, 2021 - 2033 (USD Million)
  • Fig. 77 Chronic Total Occlusion Devices Market, 2021 - 2033 (Unit Volume, In Thousand Units)
  • Fig. 78 Embolic Protection Devices Market, 2021 - 2033 (USD Million)
  • Fig. 79 Embolic Protection Devices Market, 2021 - 2033 (Unit Volume, In Thousand Units)
  • Fig. 80 US Peripheral Vascular Devices and Accessories Market: Application Outlook Key Takeaways
  • Fig. 81 US Peripheral Vascular Devices and Accessories Market: Application Movement Analysis
  • Fig. 82 Peripheral Arterial Disease (PAD) Market, 2021 - 2033 (USD Million)
  • Fig. 83 Aneurysms Market, 2021 - 2033 (USD Million)
  • Fig. 84 Venous Diseases Market, 2021 - 2033 (USD Million)
  • Fig. 85 Others Market, 2021 - 2033 (USD Million)
  • Fig. 86 US Peripheral Vascular Devices and Accessories Market: End Use Outlook Key Takeaways
  • Fig. 87 US Peripheral Vascular Devices and Accessories Market: End Use Movement Analysis
  • Fig. 88 Hospitals Market, 2021 - 2033 (USD Million)
  • Fig. 89 Ambulatory Surgical Canters Market, 2021 - 2033 (USD Million)
  • Fig. 90 Others Market, 2021 - 2033 (USD Million)
  • Fig. 91 Strategy Framework